It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
GW Pharmaceuticals: "I'm saying that it's a big speculative stock, and I do believe that medical marijuana needs to be standardized. That is what GW Pharma has, but boy is it ever speculative."
Novocure: "That should be higher. That stock has come down a lot. Holy cow! We think it's an OK stock. I want to be a buyer of it. I like the CEO."
Edwards Lifesciences Corp: "This is a Brexit stock. It's already up 25 percent for the year, that's why it sold off. There were some negative articles about it that I think are sending people off the scent. You don't have to break the chest cavity to do to this, this is the future. I think you should buy the stock."
B&G Foods: "We had a big win with that one for everybody, BGS. I wish the company would come back because it's just got a great panoply of companies and brand names within it. The stock has had a run but it still yields 3.7 percent. I'm going to hesitate recommending it all the way up here though, because boy we recommended it literally in the $20s and it's at $45."
American Tower Corp: "This week we reiterated that we think it's a buy. Why? Because it's the way around having to put up a lot of different towers. You just rent some towers, and they've got the right ones."
LTC Properties Inc: "No, if I'm going to go long-term care I am still going to send you — even after all this — to Deb Cafaro [CEO of Accenture]."
Patrick Industries: "This is one of those housing plays that is just a very good stock. What can I say? Now that the Fed is on hold with interest rates, it will probably continue."
Frontline Ltd: "No, we are passing on Frontline. We feel really good about the Nordic American Tanker deal with Exxon. That is the one I'm back on. Herbjorn Hansson [CEO] is making money for his shareholders."